UPMC announced Friday that they are making significant headway with a developing COVID-19 treatment: monoclonal antibodies.
UPMC: Monoclonal Antibody Treatment Reduces Risk Of Hospitalizations
Credit: KDKA CBS 2 Pittsburgh
Duration: 00:29s
0 shares
1 views